{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:02:03Z","timestamp":1787022123863,"version":"build-2736575974"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["NHSP Scholarship"],"award-info":[{"award-number":["NHSP Scholarship"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007696","name":"Oticon Fonden","doi-asserted-by":"publisher","award":["15-3622"],"award-info":[{"award-number":["15-3622"]}],"id":[{"id":"10.13039\/501100007696","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Concurrent chemoradiotherapy using weekly cisplatin remains standard of care for locally advanced cervical cancer in Sub-Saharan Africa. While cisplatin remains a popular cancer chemotherapeutic, it has an irreversible ototoxic effect on patients\u2019 auditory system. However, there is a paucity of epidemiological information on its extent and severity during cervical cancer treatment. In a region with a high burden of cervical cancer, this has serious consequences for aural intervention and rehabilitation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      Using a prospective cohort study design, 82 patients with incident cervical cancer, receiving weekly cisplatin chemotherapy (50 mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      body surface) at a tertiary level hospital in KwaZulu-Natal Province of South Africa, underwent audiological assessments at various intervals. We describe the temporal impact of cisplatin exposure on hearing loss, its combined effect with HIV-infection, and estimate ototoxicity incidence in this cohort. The median age was 52 years with Stages IIB (45%) and IIIB (35.4%) cancers being most common. Complaints of reduced hearing sensitivity increased significantly (p&lt;0.0001). Bilateral, asymmetrical sensorineural hearing loss, with greater effect in the extended high-frequency range, was evident. Cisplatin dosage was significantly associated with ototoxicity severity at one- (p = 0.017), three- (p = 0.010), and six-month (p = 0.015) post-treatment follow-up. HIV-seropositivity (53.7%) was significantly associated with NCI-CTCAE Grading Scale at three- (p = 0.022) and six-months (p = 0.023) post-treatment. Multiple Tobit regression revealed a cumulative dose effect bilaterally, after adjustment for age and HIV status, evident from 9000Hz and above in the right ear, while a plateau effect was observed at 250mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      in the left ear. The incidence was ototoxicity was 98% at a cumulative dose of 150mg\/m\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings of this epidemiologic study highlight the temporal course and severity of ototoxicity experienced by cervical cancer patients treated with cisplatin, with greater impact in HIV-positive subgroup, thus underscores the need for audiological monitoring and timely interventions in this cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0283639","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T13:44:07Z","timestamp":1680615847000},"page":"e0283639","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5282-6144","authenticated-orcid":true,"given":"Jessica","family":"Paken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9638-8729","authenticated-orcid":true,"given":"Cyril Devadas","family":"Govender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mershen","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merga","family":"Feyasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash","family":"Sewram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"issue":"3","key":"pone.0283639.ref001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"pone.0283639.ref002","unstructured":"Global Cancer Observatory: Cancer Tomorrow. Lyon, France: International Agency for Research on Cancer. Available from: https:\/\/gco.iarc.fr\/tomorrow, accessed [25 May 2021]."},{"key":"pone.0283639.ref003","author":"South African National Cancer Registry","year":"2017","journal-title":"Cancer in South Africa"},{"issue":"32","key":"pone.0283639.ref004","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","author":"G Liu","year":"2018","journal-title":"AIDS"},{"issue":"7","key":"pone.0283639.ref005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1200\/GO.20.00079","article-title":"Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management.","author":"LM Burt","year":"2021","journal-title":"JCO Global Oncology"},{"issue":"1","key":"pone.0283639.ref006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/20742835.2018.1441694","article-title":"Tumour and treatment factors influencing the outcome of chemo-radiation in stage IIB cervical cancer: a single institution experience","volume":"10","author":"M Jemu","year":"2018","journal-title":"Southern African Journal of Gynaecological Oncology"},{"issue":"1","key":"pone.0283639.ref007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40199-017-0178-9","article-title":"Adverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study.","volume":"25","author":"MB Visacri","year":"2017","journal-title":"Daru"},{"issue":"3","key":"pone.0283639.ref008","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/jrr\/rrs121","article-title":"Comparison of hematological toxicities between innovator and generic cisplatin formulations in cervical cancer patients treated with concurrent chemoradiotherapy","volume":"54","author":"T Oike","year":"2013","journal-title":"J Radiat Res (Tokyo)"},{"issue":"4","key":"pone.0283639.ref009","first-page":"7","article-title":"Cisplatin-based chemotherapy: Add high-frequency audiometry in the regimen","volume":"46","author":"R Arora","year":"2009","journal-title":"Indian J Cancer"},{"issue":"5","key":"pone.0283639.ref010","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4103\/0973-1482.188426","article-title":"Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study","volume":"14","author":"B Kalyanam","year":"2018","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"pone.0283639.ref011","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/toxics3030268","article-title":"Cisplatin-Induced Ototoxicity: Effects, Mechanisms and Protection Strategies.","volume":"3","author":"A Callejo","year":"2015","journal-title":"Toxics."},{"issue":"11","key":"pone.0283639.ref012","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/pbc.25123","article-title":"Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.","volume":"61","author":"E Peleva","year":"2014","journal-title":"PBC Pediatric Blood & Cancer."},{"issue":"6","key":"pone.0283639.ref013","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1200\/JCO.2006.10.077","article-title":"Relationship between cisplatin administration and the development of ototoxicity","volume":"24","author":"JM Rademaker-Lakhai","year":"2006","journal-title":"J Clin Oncol"},{"issue":"23","key":"pone.0283639.ref014","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.","volume":"34","author":"RD Frisina","year":"2016","journal-title":"J Clin Oncol"},{"key":"pone.0283639.ref015","first-page":"85","article-title":"Early detection of platinum-induced ototoxicity in adults.","volume":"13","author":"E D\u2019heygere","year":"2017","journal-title":"B-ENT"},{"key":"pone.0283639.ref016","first-page":"1","article-title":"Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study.","author":"HS Haugnes","year":"2018","journal-title":"Acta Oncol"},{"key":"pone.0283639.ref017","doi-asserted-by":"crossref","first-page":"E515","DOI":"10.1002\/lary.28543","article-title":"The Relationship Between Cisplatin-related and Age-related Hearing Loss during an Extended Follow-up","volume":"130","author":"J Skalleberg","year":"2020","journal-title":"The Laryngoscope"},{"key":"pone.0283639.ref018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2016\/1809394","article-title":"Cisplatin-Associated Ototoxicity: A Review for the Health Professional.","volume":"2016","author":"J Paken","year":"2016","journal-title":"J Toxicol."},{"issue":"3","key":"pone.0283639.ref019","first-page":"105","article-title":"Hearing loss prevalence in patients with diabetes mellitus type 1.","volume":"78","author":"DA Malucelli","year":"2012","journal-title":"Braz J Otorhinolaryngol."},{"issue":"Suppl 3","key":"pone.0283639.ref020","doi-asserted-by":"crossref","first-page":"S614","DOI":"10.1007\/s12070-013-0630-1","article-title":"Effects of Hypertension on Hearing.","volume":"65","author":"S Agarwal","year":"2013","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"6","key":"pone.0283639.ref021","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1097\/AUD.0000000000000064","article-title":"Hearing Function in Patients Living with HIV\/AIDS","volume":"35","author":"AE Luque","year":"2014","journal-title":"Ear Hear"},{"key":"pone.0283639.ref022","article-title":"Audiologic management of individuals receiving cochleotoxic drug therapy.","author":"American Speech-Language and Hearing Association","year":"1994","journal-title":"ASHA;"},{"key":"pone.0283639.ref023","article-title":"Audiologic monitoring for ototoxicity and patient\u2019s management.","author":"SA Fausti","year":"2007"},{"issue":"1","key":"pone.0283639.ref024","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12905-017-0486-8","article-title":"Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program","volume":"17","author":"J Paken","year":"2017","journal-title":"BMC Women\u2019s Health"},{"issue":"1","key":"pone.0283639.ref025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12905-021-01313-5","article-title":"Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity","volume":"21","author":"J Paken","year":"2021","journal-title":"BMC Women\u2019s Health"},{"issue":"6","key":"pone.0283639.ref026","first-page":"687","article-title":"High-frequency audiometry in normal hearing military firemen exposed to noise.","volume":"76","author":"RLO da Rocha","year":"2010","journal-title":"Braz J Otorhinolaryngol."},{"key":"pone.0283639.ref027","volume-title":"American National Standards specification for audiometers","author":"American National Standards Institute","year":"2004"},{"key":"pone.0283639.ref028","volume-title":"Introduction to audiology.","author":"F Martin","year":"2009","edition":"1"},{"key":"pone.0283639.ref029","volume-title":"American Academy of Audiology Position Statement and guidelines","author":"American Academy of Audiology","year":"2009"},{"key":"pone.0283639.ref030","author":"National Cancer Institute","year":"2017","journal-title":"Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 5.0"},{"key":"pone.0283639.ref031","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archotol.1970.04310040005002","article-title":"Clinical experience with impedance audiometry","volume":"92","author":"J. Jerger","year":"1970","journal-title":"Arch Otolaryngol"},{"key":"pone.0283639.ref032","volume-title":"Handbook of Otoacoustic Emissions","author":"JW Hall","year":"2000"},{"issue":"sup4","key":"pone.0283639.ref033","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1080\/14992027.2017.1417644","article-title":"Clinical trials, ototoxicity grading scales and the audiologist\u2019s role in therapeutic decision making.","volume":"57","author":"KA King","year":"2018","journal-title":"Int J Audiol"},{"key":"pone.0283639.ref034","author":"Health Professions Council of South Africa","year":"2018","journal-title":"Audiological management of patients on treatment that includes ototoxic medications: Guidelines."},{"issue":"4","key":"pone.0283639.ref035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7196\/SAMJ.7389","article-title":"High prevalence of cisplatin-induced ototoxicity in Cape Town, South Africa","volume":"104","author":"H Whitehorn","year":"2014","journal-title":"South African Medical Journal"},{"key":"pone.0283639.ref036","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00066-018-1347-6","article-title":"Age-corrected hearing loss after chemoradiation in cervical cancer patients","volume":"194","author":"S Marnitz","year":"2018","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"pone.0283639.ref037","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3892\/ol.2012.997","article-title":"Prospective evaluation of cisplatin-and carboplatin\u2011mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients.","volume":"5","author":"A Nitz","year":"2013","journal-title":"Oncol Lett"},{"issue":"1","key":"pone.0283639.ref038","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1748-717X-4-53","article-title":"Audiological findings in patients treated with radio-and concomitant chemotherapy for head and neck tumors","volume":"4","author":"AHB Dell\u2019Aringa","year":"2009","journal-title":"Radiation Oncology"},{"issue":"5","key":"pone.0283639.ref039","first-page":"634","article-title":"Report on hearing loss in oncology","volume":"75","author":"C Schultz","year":"2009","journal-title":"Braz J Otorhinolaryngol"},{"issue":"1","key":"pone.0283639.ref040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2008.06.003","article-title":"Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer","volume":"89","author":"CL Zuur","year":"2008","journal-title":"Radiother Oncol"},{"issue":"3","key":"pone.0283639.ref041","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000421-199906000-00020","article-title":"Cisplatin ototoxicity: the importance of baseline audiometry.","volume":"22","author":"JL Nagy","year":"1999","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"pone.0283639.ref042","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer","volume":"77","author":"C Bokemeyer","year":"1998","journal-title":"Br J Cancer"},{"issue":"4","key":"pone.0283639.ref043","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00003446-198708000-00003","article-title":"Synergistic interactions of noise and other ototraumatic agents.","volume":"8","author":"FA Boettcher","year":"1987","journal-title":"Ear Hear."},{"issue":"1","key":"pone.0283639.ref044","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/14992027.2012.721935","article-title":"Auditory and otological manifestations in adults with HIV\/AIDS","volume":"52","author":"Y van der Westhuizen","year":"2013","journal-title":"Int J Audiol"},{"issue":"2","key":"pone.0283639.ref045","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hed.25434","article-title":"Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy","volume":"41","author":"CML Driessen","year":"2019","journal-title":"Head Neck"},{"issue":"3","key":"pone.0283639.ref046","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF03008019","article-title":"Study of the effects of chemotherapy on auditory function","volume":"57","author":"A Dutta","year":"2005","journal-title":"Indian Journal of Otolaryngology and Head and Neck Surgery"},{"issue":"8","key":"pone.0283639.ref047","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1288\/00005537-198808000-00014","article-title":"Ototoxicity of high\u2010dose Cisplatin by bolus administration in patients with advanced cancers and normal hearing","volume":"98","author":"J Kopelman","year":"1988","journal-title":"The Laryngoscope"},{"issue":"6","key":"pone.0283639.ref048","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3109\/00206098509078358","article-title":"The Role of High-Frequency Audiometry in Early Detection of Ototoxicity.","volume":"24","author":"WA v.d Dreschler","year":"1985","journal-title":"Audiology"},{"issue":"10","key":"pone.0283639.ref049","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0003489414534010","article-title":"A New Grading System for Ototoxicity in Adults.","volume":"123","author":"EA Theunissen","year":"2014","journal-title":"Ann Otol Rhinol Laryngol."},{"issue":"1","key":"pone.0283639.ref050","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4081\/audiores.2012.e8","article-title":"A report of extended high frequency audiometry thresholds in school-age children with no hearing complaints.","volume":"2","author":"ART Anastasio","year":"2012","journal-title":"Audiol Res."},{"issue":"2","key":"pone.0283639.ref051","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-0039-1684042","article-title":"Monitoring Protocols for Cochlear Toxicity","volume":"40","author":"SG Lord","year":"2019","journal-title":"Seminars in hearing."},{"issue":"s2","key":"pone.0283639.ref052","article-title":"Hearing health and care: the need for improved hearing loss prevention and hearing conservation practices","volume":"42","author":"AS Fausti","year":"2005","journal-title":"J Rehabil Res Dev"},{"issue":"3s","key":"pone.0283639.ref053","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1044\/2020_AJA-20-00059","article-title":"Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.","volume":"30","author":"CM Blankenship","year":"2021","journal-title":"Am J Audiol."},{"key":"pone.0283639.ref054","first-page":"41","article-title":"Cisplatin ototoxicity in gynecologic cancer patients","volume":"55","author":"LB Melamed","year":"1985","journal-title":"Cancer Treatment Reviews"},{"key":"pone.0283639.ref055","first-page":"19","article-title":"and, Tattersall MHN. Ototoxicity in patients receiving Cisplatin: importance of dose and method of drug administration","volume":"66","author":"RR Reddel","year":"1982","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"pone.0283639.ref056","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2458-11-130","article-title":"Stress and prevalence of hearing problems in the Swedish working population.","volume":"11","author":"D Hasson","year":"2011","journal-title":"BMC Public Health"},{"issue":"1","key":"pone.0283639.ref057","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy","volume":"8","author":"AM Breglio","year":"2017","journal-title":"Nature Communications"},{"issue":"11","key":"pone.0283639.ref058","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/ar.22578","article-title":"Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention.","volume":"295","author":"J Schacht","year":"2012","journal-title":"AR The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology"},{"issue":"8","key":"pone.0283639.ref059","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5002434","article-title":"Ototoxicity.","volume":"72","author":"L Rybak","year":"2007","journal-title":"Kidney Int"},{"key":"pone.0283639.ref060","first-page":"2014","article-title":"Prevention and restoration of hearing loss associated with the use of Cisplatin.","author":"F Chirtes","year":"2014","journal-title":"BioMed research international."},{"issue":"6","key":"pone.0283639.ref061","first-page":"1315","article-title":"Distortion product otoacoustic emissions and high frequency audiometry for early detection of Cisplatin induced ototoxicity","volume":"4","author":"M Teotia","year":"2017","journal-title":"International Journal of Contemporary Medical Research"},{"key":"pone.0283639.ref062","volume-title":"BRICS health and WHO country presence profile","author":"World Health Organization","year":"2017"},{"issue":"11","key":"pone.0283639.ref063","first-page":"E537","article-title":"Longitudinal studies.","volume":"7","author":"EJ Caruana","year":"2015","journal-title":"J Thorac Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0283639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T01:10:30Z","timestamp":1702170630000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0283639"}},"subtitle":[],"editor":[{"given":"Claudio","family":"Andaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":63,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0283639","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]}}}